Syndecan-1 is one of the members of the syndecan family, which comprises transmembrane proteoglycans primarily found on the surface of cells. These proteoglycans have a conserved cytoplasmic domain, a transmembrane domain, and an extracellular domain that is modified with heparan sulfate (and sometimes chondroitin sulfate) chains. Syndecan-1, in particular, plays crucial roles in various cellular processes, including cell adhesion, proliferation, migration, and differentiation. The heparan sulfate chains present on Syndecan-1 can bind to a myriad of ligands, including growth factors, chemokines, and extracellular matrix components. This allows Syndecan-1 to modulate signaling pathways and to regulate cell behavior in response to changes in the cellular environment.
Syndecan-1 inhibitors are a class of molecules designed to specifically target and reduce the activity, expression, or interactions of Syndecan-1. These inhibitors may work through various mechanisms, such as disrupting the binding of ligands to the heparan sulfate chains of Syndecan-1, blocking its interactions with intracellular signaling partners, or downregulating its expression on the cell surface. By inhibiting the functions of Syndecan-1, these molecules can influence a wide range of cellular processes in which Syndecan-1 is involved. Given the diverse roles of Syndecan-1 in cellular physiology, the study of its inhibitors can provide insights into cellular signaling, tissue regeneration, angiogenesis, and other processes. Moreover, understanding the functions and mechanisms of Syndecan-1 inhibitors can be instrumental in elucidating the broader roles of proteoglycans in cell biology and tissue homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein might suppress pathways that induce Syndecan-1 expression, thereby reducing its levels. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin can inhibit N-linked glycosylation, which may lead to reduced post-translational modification and stability of Syndecan-1. | ||||||
Thymoquinone | 490-91-5 | sc-215986 sc-215986A | 1 g 5 g | $47.00 $133.00 | 21 | |
Thymoquinone has been suggested to down-regulate Syndecan-1, particularly in some cancerous cells. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This compound inhibits MEK, potentially suppressing downstream pathways that might induce Syndecan-1 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 could potentially down-regulate pathways leading to Syndecan-1 expression. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
By inhibiting the Hedgehog signaling pathway, Cyclopamine might reduce Syndecan-1 expression in certain contexts. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor might suppress signaling pathways that enhance Syndecan-1 expression, leading to its down-regulation. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
By inhibiting the Notch signaling pathway, DAPT could potentially suppress Syndecan-1 expression in some cell types. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, might down-regulate pathways leading to increased Syndecan-1 expression, particularly in the context of cancer cells. | ||||||